Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials
Hughes, Derralynn A., Gonzalez, Derlis E., Lukina, Elena A., Mehta, Atul, Kabra, Madhulika, Elstein, Deborah, Kisinovsky, Isaac, Giraldo, Pilar, Bavdekar, Ashish, Hangartner, Thomas N., Wang, Nan, CroVolume:
90
Language:
english
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.24012
Date:
July, 2015
File:
PDF, 1009 KB
english, 2015